In April, Valisure’s President, David Light, presented at the State of the Science Symposium in Health Services Research for the Military Health System. His talk highlighted Valisure’s findings and their potential to enhance drug quality and safety within military health services, emphasizing the role of independent testing in improving outcomes for service members.
Building on this momentum, in October, Light joined (Ret.) Col. Victor Suarez to present updates on the Department of Defense (DoD) drug quality project to the Uniformed Services University Department of Pharmacology. The presentation focused on the project’s data-driven insights and their practical applications for health systems, reinforcing the importance of rigorous quality assurance practices to protect and support military personnel.
Valisure remains dedicated to driving innovation and transparency in pharmaceutical quality, collaborating with key stakeholders to ensure the highest standards for both military and civilian healthcare systems.
In April, Valisure’s President, David Light, presented at the State of the Science Symposium in Health Services Research for the Military Health System. His talk highlighted Valisure’s findings and their potential to enhance drug quality and safety within military health services, emphasizing the role of independent testing in improving outcomes for service members.
Building on this momentum, in October, Light joined (Ret.) Col. Victor Suarez to present updates on the Department of Defense (DoD) drug quality project to the Uniformed Services University Department of Pharmacology. The presentation focused on the project’s data-driven insights and their practical applications for health systems, reinforcing the importance of rigorous quality assurance practices to protect and support military personnel.
Valisure remains dedicated to driving innovation and transparency in pharmaceutical quality, collaborating with key stakeholders to ensure the highest standards for both military and civilian healthcare systems.
In April, Valisure’s President, David Light, presented at the State of the Science Symposium in Health Services Research for the Military Health System. His talk highlighted Valisure’s findings and their potential to enhance drug quality and safety within military health services, emphasizing the role of independent testing in improving outcomes for service members.
Building on this momentum, in October, Light joined (Ret.) Col. Victor Suarez to present updates on the Department of Defense (DoD) drug quality project to the Uniformed Services University Department of Pharmacology. The presentation focused on the project’s data-driven insights and their practical applications for health systems, reinforcing the importance of rigorous quality assurance practices to protect and support military personnel.
Valisure remains dedicated to driving innovation and transparency in pharmaceutical quality, collaborating with key stakeholders to ensure the highest standards for both military and civilian healthcare systems.
In April, Valisure’s President, David Light, presented at the State of the Science Symposium in Health Services Research for the Military Health System. His talk highlighted Valisure’s findings and their potential to enhance drug quality and safety within military health services, emphasizing the role of independent testing in improving outcomes for service members.
Building on this momentum, in October, Light joined (Ret.) Col. Victor Suarez to present updates on the Department of Defense (DoD) drug quality project to the Uniformed Services University Department of Pharmacology. The presentation focused on the project’s data-driven insights and their practical applications for health systems, reinforcing the importance of rigorous quality assurance practices to protect and support military personnel.
Valisure remains dedicated to driving innovation and transparency in pharmaceutical quality, collaborating with key stakeholders to ensure the highest standards for both military and civilian healthcare systems.